[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PH24451A - New pteridines and their use as pharmaceuticla agents - Google Patents

New pteridines and their use as pharmaceuticla agents

Info

Publication number
PH24451A
PH24451A PH33161A PH33161A PH24451A PH 24451 A PH24451 A PH 24451A PH 33161 A PH33161 A PH 33161A PH 33161 A PH33161 A PH 33161A PH 24451 A PH24451 A PH 24451A
Authority
PH
Philippines
Prior art keywords
pharmaceuticla
agents
pteridines
new
new pteridines
Prior art date
Application number
PH33161A
Inventor
Josef Roch
Armin Heckel
Josef Nickl
Erich Muller
Berthold Narr
Rainer Zimmermann
Hans Weisenberger
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of PH24451A publication Critical patent/PH24451A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
PH33161A 1984-12-12 1985-12-11 New pteridines and their use as pharmaceuticla agents PH24451A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843445298 DE3445298A1 (en) 1984-12-12 1984-12-12 NEW PTERIDINE, METHOD FOR THE PRODUCTION AND USE THEREOF AS INTERMEDIATE PRODUCTS OR AS A MEDICINAL PRODUCT

Publications (1)

Publication Number Publication Date
PH24451A true PH24451A (en) 1990-06-25

Family

ID=6252576

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33161A PH24451A (en) 1984-12-12 1985-12-11 New pteridines and their use as pharmaceuticla agents

Country Status (15)

Country Link
EP (1) EP0185259A3 (en)
JP (1) JPS61140585A (en)
AU (1) AU576924B2 (en)
CA (1) CA1252783A (en)
DE (1) DE3445298A1 (en)
DK (1) DK161327C (en)
ES (1) ES8707238A1 (en)
FI (1) FI82696C (en)
GR (1) GR852996B (en)
IL (1) IL77294A (en)
NO (1) NO161373C (en)
NZ (1) NZ214522A (en)
PH (1) PH24451A (en)
PT (1) PT81650B (en)
ZA (1) ZA859462B (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
WO2003002064A2 (en) * 2001-06-28 2003-01-09 Essential Therapeutics, Inc. Fused pyrimidine dhfr inhibitors as antibacterials
DE10202468A1 (en) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridine derivatives, process for their preparation and their use
ES2295897T3 (en) * 2003-08-29 2008-04-16 4 Aza Ip Nv IMMUNODEPRESSING EFFECTS OF PTERIDINE DERIVATIVES.
CA2537224A1 (en) * 2003-10-17 2005-05-06 4 Aza Bioscience Nv Heterocycle-substituted pteridine derivatives and their use in therapy
GB2407089A (en) * 2003-10-17 2005-04-20 4 Aza Bioscience Nv Pteridine derivatives
AU2005221614A1 (en) * 2004-03-04 2005-09-22 Neurogen Corporation Arylalkylamino-substituted quinazoline analogues
DE102004057595A1 (en) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted pteridines for the treatment of inflammatory diseases
DE102004057618A1 (en) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituted pteridines for the treatment of inflammatory diseases
DE102004057645A1 (en) 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New substituted pteridine compounds, useful as phosphodiesterase 4 inhibitors for treating e.g. inflammatory diseases, cancer, asthma, ulcerative colitis, depression and schizophrenia
DE102004057594A1 (en) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitute pteridine for the treatment of inflammatory diseases
RU2445315C2 (en) * 2005-11-22 2012-03-20 Кудос Фармасьютиклз Лимитед PYRIDO-, PYRAZO- AND PYRIMIDO-PYRIMIDINE DERIVATIVES AND USE THEREOF AS mTOR INHIBITORS
KR101464384B1 (en) * 2005-11-22 2014-11-21 쿠도스 파마슈티칼스 리미티드 As mTOR inhibitors, pyridopyrimidine, pyrazopyrimidine and pyrimidopyrimidine derivatives
EP2032585B1 (en) 2006-05-24 2014-07-23 Boehringer Ingelheim International GmbH Substituted pteridines as therapeutic agents
WO2008009079A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
WO2008009078A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
US7902189B2 (en) 2006-08-23 2011-03-08 Astrazeneca Ab Compounds
CN102137860B (en) 2008-06-20 2013-08-28 阿斯利康(瑞典)有限公司 Pyrimidines composition and method for preparing same
EP3722297A1 (en) 2015-03-04 2020-10-14 Gilead Sciences, Inc. Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds
EP3507288B1 (en) 2016-09-02 2020-08-26 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
PL3507276T3 (en) 2016-09-02 2022-02-21 Gilead Sciences, Inc. Toll like receptor modulator compounds
TWI751516B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI751517B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TW202115056A (en) 2019-06-28 2021-04-16 美商基利科學股份有限公司 Processes for preparing toll-like receptor modulator compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3159628A (en) * 1962-05-28 1964-12-01 Smith Kline French Lab Pteridine-5-oxide derivatives
DE3323932A1 (en) * 1983-07-02 1985-01-10 Dr. Karl Thomae Gmbh, 7950 Biberach NEW 2-PIPERAZINO-PTERIDINE, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND

Also Published As

Publication number Publication date
JPS61140585A (en) 1986-06-27
AU576924B2 (en) 1988-09-08
DK572685D0 (en) 1985-12-11
DK572685A (en) 1986-06-13
DE3445298A1 (en) 1986-06-12
NZ214522A (en) 1988-07-28
EP0185259A3 (en) 1989-03-01
CA1252783A (en) 1989-04-18
FI82696B (en) 1990-12-31
FI854862A0 (en) 1985-12-10
ES549806A0 (en) 1987-07-16
NO161373B (en) 1989-05-02
DK161327B (en) 1991-06-24
FI854862A (en) 1986-06-13
NO854965L (en) 1986-06-13
ES8707238A1 (en) 1987-07-16
EP0185259A2 (en) 1986-06-25
AU5123285A (en) 1986-06-19
GR852996B (en) 1986-04-16
ZA859462B (en) 1987-07-29
FI82696C (en) 1991-04-10
IL77294A (en) 1989-02-28
PT81650B (en) 1988-04-21
PT81650A (en) 1986-01-01
NO161373C (en) 1989-08-09
DK161327C (en) 1991-12-09

Similar Documents

Publication Publication Date Title
GB2159516B (en) Azaphthalocyanines and their use as photoactivators
PH24451A (en) New pteridines and their use as pharmaceuticla agents
DE3666855D1 (en) Alcalisilicate compositions and their use
IL78934A0 (en) Alfuzosine compositions and use
GB8614549D0 (en) Contrast agents
GB8613493D0 (en) Diester-dtpa-paramagnetic contrast agents
EP0177158A3 (en) Thickening agents and the manufacture and use thereof
EP0204659A3 (en) Polyepoxydes and their use
ZA857124B (en) 13-halomilbemycins and 13-hydroxymilbemycins
EP0181267A3 (en) Fibrinolysis-enhancing agents
DE3660256D1 (en) Camphor-di-thiolene-complexes and their use
ZA853379B (en) Substituted 1-oxa-dethiachphalosporins as anti-inflammatory and antidegenerative agents
PH23498A (en) 3-carbonyl-1-aminoalkyl-1h-indoles,composition and use thereof
EP0255801A3 (en) Anilinotriazines and their use
DE3562486D1 (en) Arginyl-3-carboxy-4-hydroxyanilide and their use
GB2169508B (en) Ophthalmic compositions and use
AU568750B2 (en) Imidazo-pyrrolo-pyridines and their use as herbacides
IL75366A0 (en) Substituted phenylsulphonylureas,their preparation and their use as plant-treatment agents
PH23727A (en) Imidazolylethoxyindanes and use as antithrombotic agents
GB8500101D0 (en) Flocculating agent
DE3572976D1 (en) Acrylamidobenzoic acid derivatives and their use
PH20880A (en) Substituted benzoxepines and isochromanes
PH20347A (en) New use of dihydroergotamine
GB8529238D0 (en) Agents
ZA857767B (en) Ultra violet agents